Unnecessary PRN Use of Morphine ER Without Clear Indication or Duration
Summary
The deficiency involves the facility’s failure to ensure a resident’s drug regimen was free from unnecessary drugs, specifically related to the use of Morphine ER 15 mg ordered on an as-needed (PRN) basis without an adequate indication or duration for its use. The facility’s pain policy required evaluation of pain regimens and assessment of medication effectiveness, but the resident’s records showed inconsistencies. The Quarterly MDS documented intact cognition, no pain, no behavioral symptoms, and no scheduled or PRN pain medication use, despite the presence of a PRN Morphine ER order and documented administration of the drug on several dates. Resident #131 had diagnoses including COPD, renal insufficiency, and obstructive uropathy, and a care plan for pain related to primary generalized osteoarthritis with interventions to administer medications as ordered. The physician’s order, originally written and later renewed, specified Morphine ER 15 mg by mouth every 12 hours PRN, and the MAR showed the resident received this medication on multiple mornings in April. However, the MDS indicated the resident did not receive scheduled or PRN pain medications, and there was no clear documentation of an appropriate PRN indication or defined duration for the extended-release opioid. Interviews with clinical staff revealed further issues with the appropriateness and oversight of the Morphine ER regimen. The NP reported that an outside pain management specialist had ordered a standing Morphine regimen, but the resident was non-compliant with the scheduled dosing, refused appointments, and insisted on taking the medication only when they felt it was needed. The attending MD acknowledged that Morphine ER should not have been ordered on a PRN basis and that an immediate-release formulation would have been more appropriate for PRN use. The DON stated they were not aware the resident was receiving Morphine ER PRN, while the Medical Director stated the regimen worked for the resident and that residents can determine what is best for them, indicating reliance on resident preference rather than adherence to appropriate prescribing standards for PRN extended-release opioids.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.